Related Experiment Videos
Study of prognostic predictors for non-small cell lung cancer
Lung Cancer (Amsterdam, Netherlands)
|April 27, 1999
Summary
Predicting non-small cell lung cancer (NSCLC) outcomes is challenging. Advanced T and N stages, lymphatic invasion, and multiple oncoprotein expressions indicate a poor prognosis for NSCLC patients.
Area of Science:
- Oncology
- Cancer Research
- Molecular Pathology
Background:
- Treatment outcomes for non-small cell lung cancer (NSCLC) are often poor.
- Biological behavior of NSCLC can be unpredictable, hindering accurate treatment planning.
- This study investigates key prognostic predictors in NSCLC.
Purpose of the Study:
- To identify significant prognostic predictors for non-small cell lung cancer (NSCLC).
- To correlate clinical, histopathological, and molecular markers with patient outcomes.
Main Methods:
- 158 NSCLC patients underwent surgery alone or with postoperative irradiation.
- Data collected included clinical characteristics (stage, performance status), histopathology (invasion), and immunohistochemistry for oncoproteins (pan-ras, c-myc, neu, EGFR, p53) and proliferation (PCNA).
- Univariate and multivariate analyses were performed to identify independent predictors.
Main Results:
- 5-year survival, local control, and distant metastasis rates were 44%, 63%, and 40%, respectively.
- T stage, N stage, and lymphatic vessel invasion were significant predictors for survival and local control.
- N stage, lymphatic invasion, and a higher index of positive oncoprotein stains predicted increased distant metastasis.
Conclusions:
- Advanced T and N stages are independent predictors of poor survival and local control in NSCLC.
- Lymphatic vessel invasion and multi-oncoprotein overexpression are associated with increased distant metastasis.
- These factors collectively indicate a poor prognosis for NSCLC patients.